BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 24096036)

  • 21. Reduced oncotic necrosis in Fas receptor-deficient C57BL/6J-lpr mice after bile duct ligation.
    Gujral JS; Liu J; Farhood A; Jaeschke H
    Hepatology; 2004 Oct; 40(4):998-1007. PubMed ID: 15382126
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The transformation in biomarker detection and management of drug-induced liver injury.
    Church RJ; Watkins PB
    Liver Int; 2017 Nov; 37(11):1582-1590. PubMed ID: 28386997
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cholestasis increases tumor necrosis factor-related apoptotis-inducing ligand (TRAIL)-R2/DR5 expression and sensitizes the liver to TRAIL-mediated cytotoxicity.
    Higuchi H; Bronk SF; Taniai M; Canbay A; Gores GJ
    J Pharmacol Exp Ther; 2002 Nov; 303(2):461-7. PubMed ID: 12388624
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of bile duct ligation on bile acid composition in mouse serum and liver.
    Zhang Y; Hong JY; Rockwell CE; Copple BL; Jaeschke H; Klaassen CD
    Liver Int; 2012 Jan; 32(1):58-69. PubMed ID: 22098667
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biliary intervention aggravates cholestatic liver injury, and induces hepatic inflammation, proliferation and fibrogenesis in BDL mice.
    Wen YA; Liu D; Zhou QY; Huang SF; Luo P; Xiang Y; Sun S; Luo D; Dong YF; Zhang LP
    Exp Toxicol Pathol; 2011 Mar; 63(3):277-84. PubMed ID: 20149605
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanistic biomarkers provide early and sensitive detection of acetaminophen-induced acute liver injury at first presentation to hospital.
    Antoine DJ; Dear JW; Lewis PS; Platt V; Coyle J; Masson M; Thanacoody RH; Gray AJ; Webb DJ; Moggs JG; Bateman DN; Goldring CE; Park BK
    Hepatology; 2013 Aug; 58(2):777-87. PubMed ID: 23390034
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The BH3-only protein bid does not mediate death-receptor-induced liver injury in obstructive cholestasis.
    Nalapareddy Pd; Schüngel S; Hong JY; Manns MP; Jaeschke H; Vogel A
    Am J Pathol; 2009 Sep; 175(3):1077-85. PubMed ID: 19661444
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Electroacupuncture Ameliorates Intestinal Barrier Destruction in Mice With Bile Duct Ligation-Induced Liver Injury by Activating the Cholinergic Anti-Inflammatory Pathway.
    Lei W; Zhao C; Sun J; Jin Y; Duan Z
    Neuromodulation; 2022 Dec; 25(8):1122-1133. PubMed ID: 35300921
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TRAIL mediates liver injury by the innate immune system in the bile duct-ligated mouse.
    Kahraman A; Barreyro FJ; Bronk SF; Werneburg NW; Mott JL; Akazawa Y; Masuoka HC; Howe CL; Gores GJ
    Hepatology; 2008 Apr; 47(4):1317-30. PubMed ID: 18220275
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tetrathiomolybdate protects against bile duct ligation-induced cholestatic liver injury and fibrosis.
    Song M; Song Z; Barve S; Zhang J; Chen T; Liu M; Arteel GE; Brewer GJ; McClain CJ
    J Pharmacol Exp Ther; 2008 May; 325(2):409-16. PubMed ID: 18299419
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IL-17A synergistically enhances bile acid-induced inflammation during obstructive cholestasis.
    O'Brien KM; Allen KM; Rockwell CE; Towery K; Luyendyk JP; Copple BL
    Am J Pathol; 2013 Nov; 183(5):1498-1507. PubMed ID: 24012680
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of time-related changes after experimental bile duct ligation.
    Georgiev P; Jochum W; Heinrich S; Jang JH; Nocito A; Dahm F; Clavien PA
    Br J Surg; 2008 May; 95(5):646-56. PubMed ID: 18196571
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional importance of ICAM-1 in the mechanism of neutrophil-induced liver injury in bile duct-ligated mice.
    Gujral JS; Liu J; Farhood A; Hinson JA; Jaeschke H
    Am J Physiol Gastrointest Liver Physiol; 2004 Mar; 286(3):G499-507. PubMed ID: 14563671
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel murine model of reversible bile duct obstruction demonstrates rapid improvement of cholestatic liver injury.
    Taylor SA; Yeap XY; Wang JJ; Gromer KD; Kriegermeier A; Green RM; Zhang ZJ
    Physiol Rep; 2020 May; 8(10):e14446. PubMed ID: 32441483
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-Inflammatory Activity of Dehydroandrographolide by TLR4/NF-κB Signaling Pathway Inhibition in Bile Duct-Ligated Mice.
    Weng Z; Chi Y; Xie J; Liu X; Hu J; Yang F; Li L
    Cell Physiol Biochem; 2018; 49(3):1083-1096. PubMed ID: 30196285
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protective effect of the aqueous extract from the root of Platycodon grandiflorum on cholestasis-induced hepatic injury in mice.
    Kim TW; Lee HK; Song IB; Kim MS; Hwang YH; Lim JH; Park SJ; Lee SW; Kim JW; Yun HI
    Pharm Biol; 2012 Dec; 50(12):1473-8. PubMed ID: 23035893
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kupffer cells abrogate cholestatic liver injury in mice.
    Gehring S; Dickson EM; San Martin ME; van Rooijen N; Papa EF; Harty MW; Tracy TF; Gregory SH
    Gastroenterology; 2006 Mar; 130(3):810-22. PubMed ID: 16530521
    [TBL] [Abstract][Full Text] [Related]  

  • 38. D-chiro-inositol effectively attenuates cholestasis in bile duct ligated rats by improving bile acid secretion and attenuating oxidative stress.
    Zhao SS; Li NR; Zhao WL; Liu H; Ge MX; Zhang YX; Zhao LY; You XF; He HW; Shao RG
    Acta Pharmacol Sin; 2018 Feb; 39(2):213-221. PubMed ID: 28748913
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CHOP deficiency attenuates cholestasis-induced liver fibrosis by reduction of hepatocyte injury.
    Tamaki N; Hatano E; Taura K; Tada M; Kodama Y; Nitta T; Iwaisako K; Seo S; Nakajima A; Ikai I; Uemoto S
    Am J Physiol Gastrointest Liver Physiol; 2008 Feb; 294(2):G498-505. PubMed ID: 18174271
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The traditional ayurvedic medicine, Eugenia jambolana (Jamun fruit), decreases liver inflammation, injury and fibrosis during cholestasis.
    Donepudi AC; Aleksunes LM; Driscoll MV; Seeram NP; Slitt AL
    Liver Int; 2012 Apr; 32(4):560-73. PubMed ID: 22212619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.